Epigenomics AG, DE000A11QW50
19.11.2019 - 11:34:00Epigenomics AG: Correction of a release from 15/11/2019 according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
1. Details of issuer Name: Epigenomics AG Street: Geneststraße 5 Postal code: 10829 City: BerlinGermany Legal Entity Identifier (LEI): 549300X1C4U862NDLN97 2. Reason for notification X Acquisition/disposal of shares with voting rights Acquisition/disposal of instruments Change of breakdown of voting rights Other reason: 3. Details of person subject to the notification obligation Natural person (first name, surname): Roberto MignoneDate of birth: 22 Aug 1971 4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.Bridger Healthcare Ltd., Swiftcurrent Partners, L.P. 5. Date on which threshold was crossed or reached: 08 Nov 2019 6. Total positions % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) Total of both in % (7.a. + 7.b.) Total number of voting rights pursuant to Sec. 41 WpHG New 9.66 % 0 % 9.66 % 43527692 Previous notification 3.75 % 0 % 3.75 % / 7. Details on total positions a. Voting rights attached to shares (Sec. 33, 34 WpHG) ISIN Absolute In % Direct (Sec. 33 WpHG) Indirect (Sec. 34 WpHG) Direct (Sec. 33 WpHG) Indirect (Sec. 34 WpHG) DE000A11QW50 0 4205000 0 % 9.66 % Total 4205000 9.66 % b.1. Instruments according to Sec. 38 (1) no. 1 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in % % Total % b.2. Instruments according to Sec. 38 (1) no. 2 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in % % Total % 8. Information in relation to the person subject to the notification obligation Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.). X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more) Mr. Roberto Mignone % % % Bridger Management LLC 9.66 % % 9.66 % Mr. Roberto Mignone % % % Bridger Capital LLC % % % Shearwater Onshore LLC % % % Bridger Healthcare Ltd 4.03 % % % Mr. Roberto Mignone % % % Bridger Capital LLC % % % Swiftcurrent Partners LP 3.10 % % % 9. In case of proxy voting according to Sec. 34 para. 3 WpHG (only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG) Date of general meeting: Holding total positions after general meeting (6.) after annual general meeting:Proportion of voting rights Proportion of instruments Total of both % % % 10. Other explanatory remarks: Date14 Nov 2019
19.11.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
Language: English Company: Epigenomics AG Geneststraße 5 10829 BerlinGermany Internet: www.epigenomics.com End of News DGAP News Service
916127 19.11.2019
